The Latest Breaking News from diabetes

Our environments play a crucial role in chronic conditions like heart disease, says physician Rosalind J. Wright.

Teladoc is a beaten-down telehealth stock that trades at a steep discount to consensus analyst estimates in Q1 of 2024.

Danielle Carr-Gomm, died at Cleeve House in Seend, Wiltshire, where she was taking part in the workshop in October 2016

By studying the different bacteria and viruses in the bowels of diabetes patients, we could develop new treatments

A recent study revealed that exposure to light between 12:30 a.m. and 6 a.m., is linked to a 67% increased risk of developing diabetes.

With weight loss and diabetes drugs in high demand and short supply, potentially dangerous counterfeits have flooded the market.

The recent announcement that China approved Novo Nordisk's Wegovy is huge. Here's why: In a national survey conducted during 2015-2019 by China’s National Health Commission, more than half of the adult population was either overweight or obese. That's a massive market that just opened up for NVO.

Researchers warned there is a ‘lack of consistent and high-quality evidence’ over the devices for people who do not have diabetes.

Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy

Findings are first to provide evidence that chemical’s administration increases type 2 diabetes risk, researchers say

According to the study results published in the journal eBiomedicine, children born underweight face greater health risks if they develop obesity.